Vivos (RDGL) EBT Margin Growth (3y) (2014 - 2025)
Vivos (RDGL) EBT Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 1,391.00 |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -176.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 2,114.00 |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 650,059.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 650,059.00 |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | 319,694.00 |
| Mar 31, 2025 | 226,329.00 |
| Sep 30, 2024 | -1.52 Mn |
| Sep 30, 2023 | -760,141.00 |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 410,461.00 |
| Sep 30, 2019 | -451,954.00 |
| Mar 31, 2017 | -257,151.00 |
| Sep 30, 2016 | -302,301.00 |
| Mar 31, 2016 | -14.08 Mn |
| Sep 30, 2015 | -1.74 Mn |
| Mar 31, 2015 | 1.47 Mn |
| Jun 30, 2014 | -1.18 Mn |
| Mar 31, 2014 | -720,853.00 |